SCHEMBL4018634

SCHEMBL4018634

CCCCCCCC/C=C\CCCCCCCCC(CCCCCCCC/C=C\CCCCCCCC)C(C)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.49
FFAR4 Q5NUL3 1/20 0.49
FAAH O00519 4/20 0.47
TRPV1 Q8NER1 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
CYP3A4 P08684 2/20 0.46
TERT O14746 3/20 0.46
PTPN1 P18031 3/20 0.46
PPARG P37231 3/20 0.46
PPARD Q03181 3/20 0.46
PPARA Q07869 3/20 0.46
CYP1A2 P05177 2/20 0.46
MAPT P10636 2/20 0.46
CYP2C19 P33261 2/20 0.46
BLM P54132 2/20 0.46
HSD17B10 Q99714 2/20 0.46
FABP4 P15090 2/20 0.46
GMNN O75496 1/20 0.46
USP2 O75604 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10538656 0.89 MEN1 (0.44) FFAR1FFAR4FAAHTRPV1KMT2A
SCHEMBL29270002 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL18893466 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL29269913 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL4018872 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL29270010 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL29270080 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL18589805 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL30873110 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT
SCHEMBL30873138 0.87 SPHK1 (0.54) FFAR1FFAR4CYP3A4CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059257-A2 USE OF GLYCOLIPIDS AS ADJUVANTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2009-05-20 EP disclosed
WO-2008028667-A2 USE OF GLYCOLIPIDS AS ADJUVANTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2008-03-13 WO disclosed